Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Dietary Patterns and Mortality in a Multinational Cohort of Adults Receiving Hemodialysis.

Saglimbene VM, Wong G, Teixeira-Pinto A, Ruospo M, Garcia-Larsen V, Palmer SC, Natale P, Campbell K, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM; DIET-HD Investigators and Dieticians.

Am J Kidney Dis. 2019 Sep 9. pii: S0272-6386(19)30851-0. doi: 10.1053/j.ajkd.2019.05.028. [Epub ahead of print]

PMID:
31515137
2.

Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease.

Iannone A, Ruospo M, Palmer SC, Principi M, Barone M, Di Leo A, Strippoli GFM.

Aliment Pharmacol Ther. 2019 Sep 9. doi: 10.1111/apt.15493. [Epub ahead of print] Review.

PMID:
31502284
3.

Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study.

Ruospo M, Palmer SC, Graziano G, Natale P, Saglimbene V, Petruzzi M, De Benedittis M, Craig JC, Johnson DW, Ford P, Tonelli M, Celia E, Gelfman R, Leal MR, Török M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, Del Castillo D, Schön S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Strippoli GFM; ORAL-D Investigators.

PLoS One. 2019 Jun 21;14(6):e0218684. doi: 10.1371/journal.pone.0218684. eCollection 2019.

4.

Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study.

van Zwieten A, Wong G, Ruospo M, Palmer SC, Teixeira-Pinto A, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo M, Loy CT, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GFM; COGNITIVE-HD Study Investigators.

Am J Kidney Dis. 2019 May 31. pii: S0272-6386(19)30705-X. doi: 10.1053/j.ajkd.2019.03.424. [Epub ahead of print]

PMID:
31160141
5.

Interventions for improving sleep quality in people with chronic kidney disease.

Natale P, Ruospo M, Saglimbene VM, Palmer SC, Strippoli GF.

Cochrane Database Syst Rev. 2019 May 26;5:CD012625. doi: 10.1002/14651858.CD012625.pub2.

PMID:
31129916
6.

Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials.

Saglimbene VM, Wong G, van Zwieten A, Palmer SC, Ruospo M, Natale P, Campbell K, Teixeira-Pinto A, Craig JC, Strippoli GFM.

Clin Nutr. 2019 Mar 14. pii: S0261-5614(19)30095-0. doi: 10.1016/j.clnu.2019.02.041. [Epub ahead of print]

7.

Topical medical therapy and ocular perfusion pressure in open angle glaucoma: a systematic review and meta-analysis.

Rennie G, Wilkinson A, White A, Ruospo M, Teixeira-Pinto A, Strippoli G.

Curr Med Res Opin. 2019 Aug;35(8):1421-1431. doi: 10.1080/03007995.2019.1595553. Epub 2019 Apr 29.

PMID:
30880485
8.

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.

Saglimbene V, Palmer SC, Ruospo M, Natale P, Maione A, Nicolucci A, Vecchio M, Tognoni G, Craig JC, Pellegrini F, Lucisano G, Hegbrant J, Ariano R, Lamacchia O, Sasso A, Morano S, Filardi T, De Cosmo S, Pugliese G, Procaccini DA, Gesualdo L, Palasciano G, Johnson DW, Tonelli M, Strippoli GFM; Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators.

J Am Soc Nephrol. 2018 Dec;29(12):2890-2899. doi: 10.1681/ASN.2018040443. Epub 2018 Nov 12.

PMID:
30420421
9.

Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.

Iannone A, Ruospo M, Wong G, Barone M, Principi M, Di Leo A, Strippoli GFM.

Can J Gastroenterol Hepatol. 2018 Sep 16;2018:5437135. doi: 10.1155/2018/5437135. eCollection 2018.

10.

The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review.

Palmer SC, Ruospo M, Teixeira-Pinto A, Craig JC, Macaskill P, Strippoli GFM.

Am J Kidney Dis. 2018 Dec;72(6):779-789. doi: 10.1053/j.ajkd.2018.06.011. Epub 2018 Aug 24.

11.

Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF.

Cochrane Database Syst Rev. 2018 Aug 22;8:CD006023. doi: 10.1002/14651858.CD006023.pub3.

12.

The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study.

Saglimbene VM, Wong G, Craig JC, Ruospo M, Palmer SC, Campbell K, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Strippoli GFM.

J Am Soc Nephrol. 2018 Jun;29(6):1741-1751. doi: 10.1681/ASN.2018010008. Epub 2018 Apr 25.

13.

Person-Centered Integrated Care for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Valentijn PP, Pereira FA, Ruospo M, Palmer SC, Hegbrant J, Sterner CW, Vrijhoef HJM, Ruwaard D, Strippoli GFM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):375-386. doi: 10.2215/CJN.09960917. Epub 2018 Feb 9.

14.

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study.

Saglimbene VM, Wong G, Ruospo M, Palmer SC, Campbell K, Larsen VG, Natale P, Teixeira-Pinto A, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM.

Clin Nutr. 2019 Feb;38(1):429-437. doi: 10.1016/j.clnu.2017.11.020. Epub 2017 Dec 6.

15.

Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study.

van Zwieten A, Wong G, Ruospo M, Palmer SC, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo M, Loy CT, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GFM; COGNITIVE-HD study investigators.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1197-1206. doi: 10.1093/ndt/gfx314.

PMID:
29186522
16.

Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.

Saglimbene VM, Palmer SC, Ruospo M, Natale P, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2017 Aug 7;8:CD009904. doi: 10.1002/14651858.CD009904.pub2. Review.

17.

Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials.

Billy CA, Lim RT, Ruospo M, Palmer SC, Strippoli GFM.

J Rheumatol. 2018 Jan;45(1):128-136. doi: 10.3899/jrheum.170137. Epub 2017 Aug 1.

PMID:
28765243
18.

The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study.

Saglimbene V, Natale P, Palmer S, Scardapane M, Craig JC, Ruospo M, Gargano L, Lucisano G, Török M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Stroumza P, Leal M, Del Castillo D, Murgo AM, Schon S, Wollheim C, Hegbrant J, Strippoli GFM.

PLoS One. 2017 Jun 20;12(6):e0179511. doi: 10.1371/journal.pone.0179511. eCollection 2017.

19.

Glucose targets for preventing diabetic kidney disease and its progression.

Ruospo M, Saglimbene VM, Palmer SC, De Cosmo S, Pacilli A, Lamacchia O, Cignarelli M, Fioretto P, Vecchio M, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2017 Jun 8;6:CD010137. doi: 10.1002/14651858.CD010137.pub2. Review.

20.

Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study.

Ruospo M, Palmer SC, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Del Castillo D, Schon S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF; ORALD Investigators.

BMC Nephrol. 2017 May 22;18(1):166. doi: 10.1186/s12882-017-0574-x.

21.

Dietary interventions for adults with chronic kidney disease.

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF.

Cochrane Database Syst Rev. 2017 Apr 23;4:CD011998. doi: 10.1002/14651858.CD011998.pub2. Review.

22.

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

Saglimbene V, Palmer SC, Craig JC, Ruospo M, Nicolucci A, Tonelli M, Johnson D, Lucisano G, Williams G, Valentini M, D'Alonzo D, Pellegrini F, Strippoli P, Salomone M, Santoro A, Maffei S, Hegbrant J, Tognoni G, Strippoli GF; CE-DOSE Study Investigators.

PLoS One. 2017 Mar 1;12(3):e0172735. doi: 10.1371/journal.pone.0172735. eCollection 2017.

23.

Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study.

Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bednarek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schön S, Wollheim C, Hegbrant J, Strippoli GF.

Nephrol Dial Transplant. 2017 Feb 1;32(2):377-384. doi: 10.1093/ndt/gfw016.

PMID:
28186569
24.

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis.

Navarese EP, Gurbel PA, Andreotti F, Kołodziejczak MM, Palmer SC, Dias S, Buffon A, Kubica J, Kowalewski M, Jadczyk T, Laskiewicz M, Jędrzejek M, Brockmeyer M, Airoldi F, Ruospo M, De Servi S, Wojakowski W, O' Connor C, Strippoli GF.

PLoS One. 2017 Feb 2;12(2):e0168726. doi: 10.1371/journal.pone.0168726. eCollection 2017. Review.

25.

Healthy Dietary Patterns and Risk of Mortality and ESRD in CKD: A Meta-Analysis of Cohort Studies.

Kelly JT, Palmer SC, Wai SN, Ruospo M, Carrero JJ, Campbell KL, Strippoli GF.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):272-279. doi: 10.2215/CJN.06190616. Epub 2016 Dec 8. Review.

26.

Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials.

Iannone A, Ruospo M, Wong G, Principi M, Barone M, Strippoli GFM, Di Leo A.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1684-1697.e11. doi: 10.1016/j.cgh.2016.11.021. Epub 2016 Nov 25. Review.

PMID:
27890853
27.

Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.

Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF.

Am J Kidney Dis. 2016 Nov;68(5):691-702. doi: 10.1053/j.ajkd.2016.05.015. Epub 2016 Jul 22. Erratum in: Am J Kidney Dis. 2017 Sep;70(3):452.

28.

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.

Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De Berardis G, Ruospo M, Natale P, Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF.

JAMA. 2016 Jul 19;316(3):313-24. doi: 10.1001/jama.2016.9400.

PMID:
27434443
29.

Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.

Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2016 May 23;(5):CD004541. doi: 10.1002/14651858.CD004541.pub3. Review.

PMID:
27210414
30.

Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis.

Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GF; ORALD Investigators.

Nephrol Dial Transplant. 2016 Oct;31(10):1647-53. doi: 10.1093/ndt/gfv413. Epub 2015 Dec 29.

PMID:
27035674
31.

COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis.

Palmer SC, Ruospo M, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo AM, Loy C, van Zwieten A, Wong G, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GF; COGNITIVE-HD Study Investigators.

BMJ Open. 2015 Dec 9;5(12):e009328. doi: 10.1136/bmjopen-2015-009328.

32.

Reducing hospital readmissions in patients with end-stage kidney disease.

Mathew AT, Strippoli GF, Ruospo M, Fishbane S.

Kidney Int. 2015 Dec;88(6):1250-1260. doi: 10.1038/ki.2015.307. Epub 2015 Oct 14. Review.

PMID:
26466320
33.

Immunosuppressive agents for treating IgA nephropathy.

Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.

Cochrane Database Syst Rev. 2015 Aug 3;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. Review.

PMID:
26235292
34.

Interventions for preventing the progression of autosomal dominant polycystic kidney disease.

Bolignano D, Palmer SC, Ruospo M, Zoccali C, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010294. doi: 10.1002/14651858.CD010294.pub2. Review.

PMID:
26171904
35.

Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study.

Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF; ORAL-D Study Investigators.

Am J Kidney Dis. 2015 Oct;66(4):666-76. doi: 10.1053/j.ajkd.2015.04.051. Epub 2015 Jun 25.

36.

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.

Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GF.

Lancet. 2015 May 23;385(9982):2047-56. doi: 10.1016/S0140-6736(14)62459-4. Review.

PMID:
26009228
37.

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF.

Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Review.

38.

Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis.

Kaminski MR, Raspovic A, McMahon LP, Strippoli GF, Palmer SC, Ruospo M, Dallimore S, Landorf KB.

Nephrol Dial Transplant. 2015 Oct;30(10):1747-66. doi: 10.1093/ndt/gfv114. Epub 2015 May 5. Review.

PMID:
25943598
39.

Statins for kidney transplant recipients.

Webster A, Palmer S, Ruospo M, Strippoli GF.

Nephrology (Carlton). 2015 Apr;20(4):304-5. doi: 10.1111/nep.12436. No abstract available.

PMID:
25810230
40.

Statins for end-stage kidney disease treated with dialysis.

Webster A, Palmer S, Ruospo M, Strippoli GF.

Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435. No abstract available.

PMID:
25810229
41.

Statins for chronic kidney disease not requiring dialysis.

Webster A, Palmer S, Ruospo M, Strippoli GF.

Nephrology (Carlton). 2015 Apr;20(4):300-1. doi: 10.1111/nep.12434. No abstract available.

PMID:
25810228
42.

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study.

Palmer SC, Ruospo M, Campbell KL, Garcia Larsen V, Saglimbene V, Natale P, Gargano L, Craig JC, Johnson DW, Tonelli M, Knight J, Bednarek-Skublewska A, Celia E, Del Castillo D, Dulawa J, Ecder T, Fabricius E, Frazão JM, Gelfman R, Hoischen SH, Schön S, Stroumza P, Timofte D, Török M, Hegbrant J, Wollheim C, Frantzen L, Strippoli GF; DIET-HD Study investigators.

BMJ Open. 2015 Mar 20;5(3):e006897. doi: 10.1136/bmjopen-2014-006897.

43.

A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.

Tong A, Rangan GK, Ruospo M, Saglimbene V, Strippoli GF, Palmer SC, Tunnicliffe DJ, Craig JC.

Nephrol Dial Transplant. 2015 May;30(5):790-800. doi: 10.1093/ndt/gfv010. Epub 2015 Jan 29. Review.

PMID:
25637642
44.

Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies.

Palmer SC, Hanson CS, Craig JC, Strippoli GF, Ruospo M, Campbell K, Johnson DW, Tong A.

Am J Kidney Dis. 2015 Apr;65(4):559-73. doi: 10.1053/j.ajkd.2014.09.012. Epub 2014 Nov 6. Review.

PMID:
25453993
45.

Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review.

Russo R, Ruospo M, Cozzolino M, De Nicola L, Icardi A, Paoletti E, Mazzaferro S.

J Nephrol. 2014 Oct;27(5):483-94. doi: 10.1007/s40620-014-0120-x. Epub 2014 Jul 11. Review.

PMID:
25012237
46.

Patient satisfaction with in-centre haemodialysis care: an international survey.

Palmer SC, de Berardis G, Craig JC, Tong A, Tonelli M, Pellegrini F, Ruospo M, Hegbrant J, Wollheim C, Celia E, Gelfman R, Ferrari JN, Törok M, Murgo M, Leal M, Bednarek-Skublewska A, Dulawa J, Strippoli GF.

BMJ Open. 2014 May 19;4(5):e005020. doi: 10.1136/bmjopen-2014-005020.

47.

Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies.

Ruospo M, Palmer SC, Craig JC, Gentile G, Johnson DW, Ford PJ, Tonelli M, Petruzzi M, De Benedittis M, Strippoli GF.

Nephrol Dial Transplant. 2014 Feb;29(2):364-75. doi: 10.1093/ndt/gft401. Epub 2013 Sep 29. Review.

PMID:
24081863
48.

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial].

Saglimbene V, D'Alonzo D, Ruospo M, Vecchio M, Natale P, Gargano L, Nicolucci A, Pellegrini F, Craig JC, Triolo G, Procaccini DA, Santoro A, Di Giulio S, La Rosa S, Murgo A, Di Toro Mammarella R, Sambati M, D'Ambrosio N, Greco V, Giannoccaro G, Flammini A, Boccia E, Montalto G, Pagano S, Amarù S, Fici M, Lumaga GB, Mancini E, Veronesi M, Patregnani L, Querques M, Schiavone P, Chimienti S, Palumbo R, Di Franco D, Della Volpe M, Gori E, Salomone M, Iacono A, Moscoloni M, Treglia A, Casu D, Piras AM, Di Silva A, Mandreoli M, Lopez A, Quarello F, Catizone L, Russo G, Forcellini S, Maccarone M, Catucci G, Di Paolo B, Stingone A, D'Angelo B, Guastoni C, Pasquali S, Minoretti C, Bellasi A, Boscutti G, Martone M, David S, Schito F, Urban L, Di Iorio B, Caruso F, Mazzoni A, Musacchio R, Andreoli D, Cossu M, Li Cavoli G, Cornacchiari M, Granata A, Clementi A, Giordano R, Guastoni C, Barzaghi W, Valentini M, Hegbrant J, Tognoni G, Strippoli GF.

G Ital Nefrol. 2013 Mar-Apr;30(2). pii: gin/30.2.21. Italian.

PMID:
23832463
49.

Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.

Strippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D, Hegbrant J, Wollheim C, Gargano L; ORAL-D Investigators.

BMC Nephrol. 2013 Apr 19;14:90. doi: 10.1186/1471-2369-14-90.

50.

The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study.

Tong A, Palmer S, Manns B, Craig JC, Ruospo M, Gargano L, Johnson DW, Hegbrant J, Olsson M, Fishbane S, Strippoli GF.

BMJ Open. 2013 Jan 24;3(1). pii: e002148. doi: 10.1136/bmjopen-2012-002148.

Supplemental Content

Loading ...
Support Center